Institutional shares held 18.2 Million
19.5K calls
13.9K puts
Total value of holdings $5.97B
$6.4M calls
$4.56M puts
Market Cap $8.09B
24,633,900 Shares Out.
Institutional ownership 73.87%
# of Institutions 456


Latest Institutional Activity in BIO

Top Purchases

Q3 2024
Van Eck Associates Corp Shares Held: 1.3M ($428M)
Q3 2024
Millennium Management LLC Shares Held: 584K ($192M)
Q3 2024
Ariel Investments, LLC Shares Held: 379K ($124M)
Q3 2024
Point72 Asset Management, L.P. Shares Held: 250K ($82.1M)
Q3 2024
Dimensional Fund Advisors LP Shares Held: 654K ($215M)

Top Sells

Q3 2024
Invesco Ltd. Shares Held: 40.3K ($13.2M)
Q3 2024
Vanguard Group Inc Shares Held: 1.91M ($626M)
Q3 2024
Bank Of America Corp Shares Held: 53K ($17.4M)
Q3 2024
Massachusetts Financial Services CO Shares Held: 54.2K ($17.8M)
Q3 2024
State Street Corp Shares Held: 636K ($209M)

About BIO

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.


Insider Transactions at BIO

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
30.9K Shares
From 11 Insiders
Exercise of conversion of derivative security 30.6K shares
Bona fide gift 285 shares
Sell / Disposition
23K Shares
From 12 Insiders
Payment of exercise price or tax liability 9.98K shares
Open market or private sale 9.49K shares
Bona fide gift 3.53K shares

Track Institutional and Insider Activities on BIO

Follow BIO-RAD LABORATORIES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIO shares.

Notify only if

Insider Trading

Get notified when an Bio Rad Laboratories, Inc. insider buys or sells BIO shares.

Notify only if

News

Receive news related to BIO-RAD LABORATORIES, INC.

Track Activities on BIO